DK515989A - Fremgangsmaade til aktivering af genteknologisk fremstillede og i prokaryoter udtrykte antistoffer - Google Patents

Fremgangsmaade til aktivering af genteknologisk fremstillede og i prokaryoter udtrykte antistoffer

Info

Publication number
DK515989A
DK515989A DK515989A DK515989A DK515989A DK 515989 A DK515989 A DK 515989A DK 515989 A DK515989 A DK 515989A DK 515989 A DK515989 A DK 515989A DK 515989 A DK515989 A DK 515989A
Authority
DK
Denmark
Prior art keywords
procaryote
procedure
expressed antibodies
mol
activating
Prior art date
Application number
DK515989A
Other languages
English (en)
Other versions
DK515989D0 (da
DK175439B1 (da
Inventor
Rainer Rudolph
Johannes Buchner
Helmut Lenz
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK515989D0 publication Critical patent/DK515989D0/da
Publication of DK515989A publication Critical patent/DK515989A/da
Application granted granted Critical
Publication of DK175439B1 publication Critical patent/DK175439B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/867—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody produced via recombinant dna technology

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
DK198905159A 1988-10-17 1989-10-17 Fremgangsmåde til aktivering af genteknologisk fremstillede og i prokaryoter udtrykte antistoffer DK175439B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3835350A DE3835350A1 (de) 1988-10-17 1988-10-17 Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
DE3835350 1988-10-17

Publications (3)

Publication Number Publication Date
DK515989D0 DK515989D0 (da) 1989-10-17
DK515989A true DK515989A (da) 1990-04-18
DK175439B1 DK175439B1 (da) 2004-10-18

Family

ID=6365312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198905159A DK175439B1 (da) 1988-10-17 1989-10-17 Fremgangsmåde til aktivering af genteknologisk fremstillede og i prokaryoter udtrykte antistoffer

Country Status (12)

Country Link
US (1) US5077392A (da)
EP (1) EP0364926B1 (da)
JP (1) JPH0793879B2 (da)
KR (1) KR920010873B1 (da)
AT (1) ATE101650T1 (da)
AU (1) AU609645B2 (da)
CA (1) CA2000604C (da)
DD (1) DD285613A5 (da)
DE (2) DE3835350A1 (da)
DK (1) DK175439B1 (da)
ES (1) ES2061876T3 (da)
IL (1) IL92012A (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US5676947A (en) * 1989-02-07 1997-10-14 Boehringer Manneheim Gmbh Method for treating thromboembolic conditions using thrombolytically active proteins
DE4037196A1 (de) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh Verfahren zur reaktivierung von denaturiertem protein
DE4105480A1 (de) * 1991-02-21 1992-08-27 Boehringer Mannheim Gmbh Verbesserte aktivierung von rekombinanten proteinen
AU3812993A (en) * 1992-03-24 1993-10-21 Synergen, Inc. Refolding and purification of insulin-like growth factor I
NZ261571A (en) * 1993-02-04 1997-03-24 Denzyme Aps Producing correctly folded proteins using multiple denaturation and renaturation cycles
EP0943690B1 (en) * 1995-12-21 2006-11-29 Ajinomoto Co., Inc. Method for refolding human activin a
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1916020A3 (en) 1997-08-15 2008-07-02 Chugai Seiyaku Kabushiki Kaisha Preventives and/or remedies for systemic lupus erythematosus containing anti-IL-6 receptor antibody as the active ingredient
DE69934585T2 (de) * 1998-07-09 2007-10-25 BaroFold, Inc., Boulder Rückfaltung von protein-aggregaten und einschlussteilchen durch hohen druck
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
WO2001019970A2 (en) * 1999-09-15 2001-03-22 Eli Lilly And Company Chymotrypsin-free trypsin
US6808902B1 (en) * 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
MXPA03003867A (es) 2000-10-31 2004-10-15 Univ Colorado Regents Desagregacion mejorada de proteina y replegamiento utilizando alta presion.
DE10105912A1 (de) * 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Rekombinante Proteinase K
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
MY143274A (en) * 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins
DE202006020194U1 (de) 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
TWI476207B (zh) 2006-07-14 2015-03-11 Genentech Inc 重組蛋白之再摺疊
US20080161242A1 (en) * 2006-09-15 2008-07-03 Randolph Theodore W High pressure treatment of proteins for reduced immunogenicity
WO2011113601A1 (en) 2010-03-17 2011-09-22 Biogenerix Ag Method for obtaining biologically active recombinant human g-csf
HUP1200171A1 (hu) 2012-03-19 2013-09-30 Richter Gedeon Nyrt Módszerek polipeptidek elõállítására
US20160060291A1 (en) * 2012-03-30 2016-03-03 Biogenomics Limited Process for renaturation of polypeptides
US20150376228A1 (en) * 2013-02-22 2015-12-31 Biogenomics Limited Process for high efficiency refolding of recombinant proteins
WO2014167574A1 (en) * 2013-03-22 2014-10-16 Biogenomics Limited Process for isolation and stabilisation of key intermediates for high efficiency refolding of recombinant proteins
US10457716B2 (en) 2014-08-06 2019-10-29 University Of Notre Dame Du Lac Protein folding and methods of using same
CN110643595A (zh) * 2019-10-21 2020-01-03 黑龙江精益检测有限公司 一种对化学修饰后磁性固定化pla1再活化的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (da) * 1982-12-22 1984-10-02 Genentech Inc
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
ES8800957A1 (es) * 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
FR2594845B1 (fr) * 1986-02-21 1989-12-01 Genetica Preparation par voie microbiologique de l'activateur tissulaire humain du plasminogene (t-pa) et conversion de l'enzyme ainsi obtenue en sa forme active
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen

Also Published As

Publication number Publication date
JPH0793879B2 (ja) 1995-10-11
DK515989D0 (da) 1989-10-17
JPH02227090A (ja) 1990-09-10
ES2061876T3 (es) 1994-12-16
KR920010873B1 (ko) 1992-12-19
DD285613A5 (de) 1990-12-19
ATE101650T1 (de) 1994-03-15
EP0364926A2 (de) 1990-04-25
DE58906984D1 (de) 1994-03-24
CA2000604A1 (en) 1990-04-17
KR900006515A (ko) 1990-05-08
AU4293189A (en) 1990-04-26
US5077392A (en) 1991-12-31
IL92012A0 (en) 1990-07-12
DK175439B1 (da) 2004-10-18
EP0364926B1 (de) 1994-02-16
CA2000604C (en) 1999-07-06
EP0364926A3 (de) 1991-05-02
AU609645B2 (en) 1991-05-02
DE3835350A1 (de) 1990-04-19
IL92012A (en) 1994-12-29

Similar Documents

Publication Publication Date Title
DK515989A (da) Fremgangsmaade til aktivering af genteknologisk fremstillede og i prokaryoter udtrykte antistoffer
PT88417A (pt) Stabilisierte humanprotein-praeparate
DK0574402T3 (da) Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
NO881904D0 (no) Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
PT93178A (pt) Agente proteico anticanceroso
NO903681D0 (no) Monoklonale antistoffer mot aktiverte ras-proteiner med aminosyremutasjoner i posisjon 13 i proteinet.
DK56386D0 (da) Reagens til ved haemagglunitation at bestemme antistoffer mod bakterielle toksiner, fremgangsmaade til fremstilling af reagenset og dettes anvendelse
DK0496973T3 (da) Porcine somatotropiner med ændringer i alfa-helix 1 regionen og kombinationer med andre mutationer.
DE69513226D1 (de) Verwendung von Azolen als Virustötende Substanzen in Lösungen von biologisch aktiven Proteinen
DK0467839T3 (da) In-vitro-behandling af fusionsproteiner
DK661489A (da) Ekspressionsplasmider til ekspression af proteiner i e. coli og deres anvendelse
DE3586795D1 (de) Absorptionsverbesserer fuer proteine.
NO893572L (no) Lunge-overflateaktivt protein og beslektet polypeptid.

Legal Events

Date Code Title Description
PUP Patent expired